The ROE as of December 2025 (TTM) for Unicycive Therapeutics, Inc. (UNCY) is -184.07%

According to Unicycive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -184.07%. This represents a change of 116.62% compared to the average of -84.97% of the last 4 quarters.

Unicycive Therapeutics, Inc. (UNCY) Historical ROE (quarterly & annually)

How has UNCY ROE performed in the past?

The mean historical ROE of Unicycive Therapeutics, Inc. over the last ten years is 652.77%. The current -184.07% ROE has changed -128.20% with respect to the historical average. Over the past ten years (40 quarters), UNCY's ROE was at its highest in in the December 2022 quarter at 1.14%. The ROE was at its lowest in in the December 2024 quarter at -289.66%.

Unicycive Therapeutics, Inc. (UNCY) ROE by Quarter and Year

Discovering the peaks and valleys of Unicycive Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unicycive Therapeutics, Inc. (UNCY) Average ROE

How has UNCY ROE performed in the past?

The current ROE of Unicycive Therapeutics, Inc. (UNCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Unicycive Therapeutics, Inc. (UNCY) ROE vs. Peers

How is UNCY’s ROE compared to its peers?

Unicycive Therapeutics, Inc.’s ROE is greater than CAMP4 Therapeutics Corporation (-131.20%), greater than Vaxart, Inc. (-123.53%), greater than Repare Therapeutics Inc. (-57.56%), greater than Biomea Fusion, Inc. (-256.98%), greater than Immunic, Inc. (-716.20%), greater than Acrivon Therapeutics, Inc. Common Stock (-53.71%), greater than PMV Pharmaceuticals, Inc. (-47.95%), greater than Relmada Therapeutics, Inc. (-223.17%), greater than MindWalk Holdings Corp. (-114.30%), greater than Cibus, Inc. (-166.90%),

Build a custom stock screener for Unicycive Therapeutics, Inc. (UNCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unicycive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unicycive Therapeutics, Inc. (UNCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unicycive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.